dextrothyroxine has been researched along with Cancer of Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bricker, LA | 1 |
| Hu, J; Le, W; Li, M; Lu, H; Yuan, Y; Zhang, T; Zhou, L; Zuo, H | 1 |
| Pedroso, AS; Poloni, JAT; Tasca, T; Trein, MR; Zanotelli, ML | 1 |
1 review(s) available for dextrothyroxine and Cancer of Liver
| Article | Year |
|---|---|
A clinical approach to the hyperlipidemias.
Topics: Aluminum; Carcinoma, Hepatocellular; Cholestasis; Cholestyramine Resin; Dextrothyroxine; Diabetes Complications; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Electrophoresis; Eye Diseases; Fats, Unsaturated; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Liver Neoplasms; Myxedema; Nephrotic Syndrome; Nicotinic Acids; Triglycerides; Xanthomatosis | 1971 |
2 other study(ies) available for dextrothyroxine and Cancer of Liver
| Article | Year |
|---|---|
Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Ivermectin; Liver Neoplasms; Mice; Sorafenib | 2022 |
Strongyloides stercoralis larvae or egg: Which came first?
Topics: Animals; Antiparasitic Agents; Carcinoma, Hepatocellular; Feces; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Ivermectin; Larva; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Ovum; Strongyloides stercoralis; Strongyloidiasis; Superinfection; Treatment Outcome | 2019 |